中国药物警戒 ›› 2025, Vol. 22 ›› Issue (7): 790-793.
DOI: 10.19803/j.1672-8629.20240887

• 安全与合理用药 • 上一篇    下一篇

268例真实世界注射用头孢拉定不良反应安全性信号挖掘

李秋荣, 傅苗青, 周白水, 李翠, 萧晓彤, 俞玉萍, 邓璐   

  1. 广东金城金素制药有限公司,广东 中山 528437
  • 收稿日期:2024-11-15 出版日期:2025-07-15 发布日期:2025-07-17
  • 作者简介:李秋荣,男,本科,工程师,药品研制与药物警戒。
  • 基金资助:
    广东金城金素制药有限公司上市后药品安全性研究课题(RWS-2302)

Mining of Real-World ADR Signals Related to Cefradine for Injection in 268 Cases

LI Qiurong, FU Miaoqing, ZHOU Baishui, LI Cui, XIAO Xiaotong, YU Yuping, DENG Lu   

  1. Guangdong KingSoo Pharmaceutical Co., Ltd., Zhongshan Guangdong 528437, China
  • Received:2024-11-15 Online:2025-07-15 Published:2025-07-17

摘要: 目的 分析注射用头孢拉定的药品不良反应(ADR)信号,为临床安全用药提供参考。方法 采用报告比值比(ROR)和贝叶斯置信传播神经网络(BCPNN)法对注射用头孢拉定2017年1月1日至2023年12月31日安全性数据库中的个例安全性报告(ICSRs)进行信号挖掘与分析。结果 纳入268份(428例次)ICSRs检出15个注射用头孢拉定的重叠信号。其中说明书已载明7个预期ADR信号分别为血尿症、注射部位痛、超敏反应、呕吐、恶心、腹部不适、腹痛;8个非预期ADR信号分别为寒热不耐受、呼吸急促、寒战、苍白、感觉减退、肿胀、头晕、潮红。结论 临床使用注射用头孢拉定需结合患者病情制定给药方案,重点关注男性、18岁以下或联用其他药物患者,监测尿常规和肾功能变化,尽量避免发生血尿症等ADR;临床还应加强药学监护,警惕寒热不耐受、呼吸急促、寒战、苍白等非预期ADR,保障患者用药安全。

关键词: 注射用头孢拉定, 报告比值比, 贝叶斯置信传播神经网络, 信号挖掘, 血尿症, 寒热不耐受

Abstract: Objective To analyze the adverse drug reaction (ADR) signals of cefradine for injection so as to provide a clinical reference for safe medication. Methods The ROR and BCPNN Methods were employed to mine and analyze signals in cefradine-related ICSRs collected between 2017 and 2023 by safety databases based on real-world data from medical institutions. Results A total of 268 cases were included, and a total of 15 overlapping signals were detected by both ROR and BCPNN Methods. Among them, there were 7 safety signals identified as expected ADR that were specified in package inserts, namely haematuria, injection-site pain, hypersensitivity, vomiting, nausea, abdominal discomfort and abdominal pain. Meanwhile there were 8 unexpected safety signals identified, including temperature intolerance, tachypnoea, chills, pallor, hypoaesthesia, swelling, dizziness and flushing. Conclusion When cefradine for injection is clinically used, dosage regimens should be determined based on the patient’s conditions. Special care has to be given to those patients who are male, or under 18 or taking a combination of drugs. Changes in urinary routine indexes and renal function should be monitored to prevent such ADR as haematuria. In addition, clinicians should provide pharmaceutical care and remain alert to unexpected potential risks in order to ensure the safety of patients.

Key words: Cefradine for Injection, ROR, BCPNN, Signal Mining, Haematuria, Temperature Intolerance

中图分类号: